BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wietzke-Braun P, Meier V, Braun F, Ramadori G. Combination of “low-dose” ribavirin and interferon alfa-2a therapy followed by interferon alfa-2a monotherapy in chronic HCV-infected non-responders and relapsers after interferon alfa-2a monotherapy. World J Gastroenterol 2001; 7(2): 222-227 [PMID: 11819764 DOI: 10.3748/wjg.v7.i2.222]
URL: https://www.wjgnet.com/1007-9327/full/v7/i2/222.htm
Number Citing Articles
1
Xue-Song Liang, Jian-Qi Lian, Yong-Xing Zhou, Qing-He Nie, Chun-Qiu Hao. A small yeast RNA inhibits HCV IRES mediated translation and inhibits replication of poliovirus <italic>in vivo</italic>World Journal of Gastroenterology 2003; 9(5): 1008-1013 doi: 10.3748/wjg.v9.i5.1008
2
Rashmi Kumar, Piyush Tripathi, Madan Baranwal, Sudhakar Singh, Sanjeev Tripathi, Gopa Banerjee. Randomized, Controlled Trial of Oral Ribavirin for Japanese Encephalitis in Children in Uttar Pradesh, IndiaClinical Infectious Diseases 2009; 48(4): 400 doi: 10.1086/596309
3
Xin-Xin Zhang, Shen-Ying Zhang, Jing Liu, Zhi-Meng Lu, Yuan Wang. Expression of hepatitis C virus hypervariable region 1 and its clinical significanceWorld Journal of Gastroenterology 2003; 9(5): 1003-1007 doi: 10.3748/wjg.v9.i5.1003
4
Xue-Bing Yan, Serena Battaglia, Delphine Boucreux, Zhi Chen, Christian Brechot, Nicole Pavio. Mapping of the interacting domains of hepatitis C virus core protein and the double-stranded RNA-activated protein kinase PKRVirus Research 2007; 125(1): 79 doi: 10.1016/j.virusres.2006.12.010
5
Perdita Wietzke-Braun, Felix Braun, Burckhart Sattler, Giuliano Ramadori, Burckhardt Ringe. Initial steroid-free immunosuppression after liver transplantation in recipients with hepatitis c virus related cirrhosisWorld Journal of Gastroenterology 2004; 10(15): 2213-2217 doi: 10.3748/wjg.v10.i15.2213
6
Song Chen, Yu-Ming Wang. Genetic evolution of structural region of hepatitis C virus in primary infectionWorld Journal of Gastroenterology 2002; 8(4): 686-693 doi: 10.3748/wjg.v8.i4.686
7
Dilek Oguz, Bahattin Cicek, Levent Filik, Bulent Odemis, Mesut Kilic, Engin Altintas, Neslihan Zengin, Emin Altiparmak. Effect of interferon and ribavirin combined with amantadine in interferon and ribavirin non-responder patients with chronic hepatitis C (genotype 1)World Journal of Gastroenterology 2005; 11(4): 580-583 doi: 10.3748/wjg.v11.i4.580
8
Yukiko Ito, Natsuyo Yamamoto, Ryo Nakata, Yoshihisa Kato, Masashi Iori, Keisuke Sakai, Tamiko Takemura, Ryosuke Tateishi, Haruhiko Yoshida, Takao Kawabe, Masao Omata. Delayed development of hepatocellular carcinoma during long-term follow-up after eradication of hepatitis C virus by interferon therapyWorld Journal of Gastroenterology 2005; 11(45): 7218-7221 doi: 10.3748/wjg.v11.i45.7218
9
Perdita Wietzke-Braun, Volker Meier, Katrin Neubauer-Saile, Sabine Mihm, Giuliano Ramadori. Treatment of genotype 2 and 3 chronic hepatitis C virus-infected patientsWorld Journal of Gastroenterology 2005; 11(39): 6188-6192 doi: 10.3748/wjg.v11.i39.6188
10
Perdita Wietzke-Braun, Felix Braun, Peter Schott, Giuliano Ramadori. Is laparoscopy an advantage in the diagnosis of cirrhosis in chronic hepatitis C virus infection?World Journal of Gastroenterology 2003; 9(4): 745-750 doi: 10.3748/wjg.v9.i4.745
11
Yan-Wei Zhong, Jun Cheng, Gang Wang, Shuang-Shuang Shi, Li Li, Ling-Xia Zhang, Ju-Mei Chen. Preparation of human single chain Fv antibody against hepatitis C virus E2 protein and its identification in immunohistochemistryWorld Journal of Gastroenterology 2002; 8(5): 863-867 doi: 10.3748/wjg.v8.i5.863